We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$116M
RCM
2
RA Capital Management
Massachusetts
$51M
O
3
OrbiMed
New York
$48.3M
NI
4
Nextech Invest
Switzerland
$31.8M -$4.53M -346,355 -12%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$29M +$3.1M +236,786 +11%
BlackRock
6
BlackRock
New York
$27.2M -$297K -22,728 -1%
VVA
7
Vida Ventures Advisors
Massachusetts
$26.4M -$7.06M -539,661 -20%
Viking Global Investors
8
Viking Global Investors
Connecticut
$21.8M
LCM
9
Lynx1 Capital Management
Puerto Rico
$20M
BC
10
Boxer Capital
California
$18.2M -$4.25M -325,000 -18%
APM
11
Avidity Partners Management
Texas
$14.5M +$15.9M +1,212,611 New
Citadel Advisors
12
Citadel Advisors
Florida
$13.1M -$407K -31,088 -3%
Vanguard Group
13
Vanguard Group
Pennsylvania
$12.1M +$200K +15,270 +2%
FCMV
14
Foresite Capital Management V
California
$10.5M
NHAS
15
Novo Holdings A/S
Denmark
$9.75M
RSCM
16
Rock Springs Capital Management
Maryland
$8.93M +$1.68M +128,589 +21%
WP
17
Woodline Partners
California
$6.27M +$3.46M +264,393 +102%
HMC
18
Harvard Management Company
Massachusetts
$5.95M
State Street
19
State Street
Massachusetts
$5.58M +$186K +14,243 +3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$5.03M +$134K +10,225 +2%
American Century Companies
21
American Century Companies
Missouri
$3.85M +$24.6K +1,879 +0.6%
Federated Hermes
22
Federated Hermes
Pennsylvania
$3.68M
FCOMV
23
Foresite Capital Opportunity Management V
California
$3.48M
DM
24
Deerfield Management
New York
$2.99M
Northern Trust
25
Northern Trust
Illinois
$2.64M -$65.2K -4,982 -2%